Jan Copeland - Publications

UNSW, Sydney, Australia 

177 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lintzeris N, Mills L, Dunlop A, Copeland J, Mcgregor I, Bruno R, Kirby A, Montebello M, Hall M, Jefferies M, Kevin R, Bhardwaj A. Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial. Drug and Alcohol Dependence. 215: 108220. PMID 32768992 DOI: 10.1016/J.Drugalcdep.2020.108220  0.01
2020 Hides L, Baker A, Norberg M, Copeland J, Quinn C, Walter Z, Leung J, Stoyanov SR, Kavanagh D. A Web-Based Program for Cannabis Use and Psychotic Experiences in Young People (Keep It Real): Protocol for a Randomized Controlled Trial. Jmir Research Protocols. 9: e15803. PMID 32723727 DOI: 10.2196/15803  0.01
2020 Weinberger AH, Zhu J, Levin J, Barrington-Trimis JL, Copeland J, Wyka K, Kim JH, Goodwin RD. Cannabis use among US adults with anxiety from 2008 to 2017: The role of state-level cannabis legalization. Drug and Alcohol Dependence. 214: 108163. PMID 32707516 DOI: 10.1016/J.Drugalcdep.2020.108163  0.01
2020 Mills L, Lintzeris N, Bruno R, Montebello M, Dunlop A, Deacon RM, Copeland J, Jefferies M, Rivas C, Mammen K. Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence. Drug and Alcohol Review. 39: 356-364. PMID 32129558 DOI: 10.1111/Dar.13050  0.01
2020 Weinberger AH, Zhu J, Lee J, Anastasiou E, Copeland J, Goodwin RD. Cannabis use among youth in the United States, 2004-2016: Faster rate of increase among youth with depression. Drug and Alcohol Dependence. 209: 107894. PMID 32126453 DOI: 10.1016/J.Drugalcdep.2020.107894  0.01
2020 Lintzeris N, Copeland J, Bruno R. Clinical Significance and Outcomes in Trial of Nabiximols for Treatment of Cannabis Dependence-Reply. Jama Internal Medicine. 180: 163-164. PMID 31904790 DOI: 10.1001/Jamainternmed.2019.5670  0.01
2019 Albertella L, Gibson L, Rooke S, Norberg MM, Copeland J. Correction to: A smartphone app intervention for adult cannabis users wanting to quit or reduce their use: a pilot evaluation. Journal of Cannabis Research. 1: 10. PMID 33531088 DOI: 10.1186/s42238-019-0010-0  1
2019 Albertella L, Gibson L, Rooke S, Norberg MM, Copeland J. A smartphone app intervention for adult cannabis users wanting to quit or reduce their use: a pilot evaluation. Journal of Cannabis Research. 1: 9. PMID 33526112 DOI: 10.1186/s42238-019-0009-6  1
2019 Jacka B, Larance B, Copeland J, Burns L, Farrell M, Jackson E, Degenhardt L. Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia. Substance Abuse. 1-7. PMID 31545138 DOI: 10.1080/08897077.2019.1635954  0.01
2019 Lintzeris N, Bhardwaj A, Mills L, Dunlop A, Copeland J, McGregor I, Bruno R, Gugusheff J, Phung N, Montebello M, Chan T, Kirby A, Hall M, Jefferies M, Luksza J, et al. Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial. Jama Internal Medicine. PMID 31305874 DOI: 10.1001/Jamainternmed.2019.1993  0.01
2019 Weinberger AH, Delnevo CD, Wyka K, Gbedemah M, Lee J, Copeland J, Goodwin RD. Cannabis use is associated with increased risk of cigarette smoking initiation, persistence, and relapse among adults in the US. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31112595 DOI: 10.1093/Ntr/Ntz085  0.01
2019 Albertella L, Gibson L, Rooke S, Norberg MM, Copeland J. Correction to: A smartphone app intervention for adult cannabis users wanting to quit or reduce their use: a pilot evaluation Journal of Cannabis Research. 1. DOI: 10.1186/s42238-019-0010-0  0.01
2019 Albertella L, Gibson L, Rooke S, Norberg MM, Copeland J. A smartphone app intervention for adult cannabis users wanting to quit or reduce their use: a pilot evaluation Journal of Cannabis Research. 1. DOI: 10.1186/s42238-019-0009-6  0.01
2018 Pacek LR, Copeland J, Dierker L, Cunningham CO, Martins SS, Goodwin RD. Among whom is cigarette smoking declining in the United States? The impact of cannabis use status, 2002-2015. Drug and Alcohol Dependence. 191: 355-360. PMID 30179761 DOI: 10.1016/J.Drugalcdep.2018.01.040  0.01
2018 Weinberger AH, Pacek LR, Wall MM, Zvolensky MJ, Copeland J, Galea S, Nahvi S, Moeller SJ, Hasin DS, Goodwin RD. Trends in cannabis use disorder by cigarette smoking status in the United States, 2002-2016. Drug and Alcohol Dependence. 191: 45-51. PMID 30077055 DOI: 10.1016/J.Drugalcdep.2018.06.016  0.01
2018 Albertella L, Le Pelley ME, Yücel M, Copeland J. Age moderates the association between frequent cannabis use and negative schizotypy over time. Addictive Behaviors. 87: 183-189. PMID 30053703 DOI: 10.1016/J.Addbeh.2018.07.016  1
2018 Bhardwaj AK, Allsop DJ, Copeland J, McGregor IS, Dunlop A, Shanahan M, Bruno R, Phung N, Montebello M, Sadler C, Gugusheff J, Jackson M, Luksza J, Lintzeris N. Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol. Bmc Psychiatry. 18: 140. PMID 29776349 DOI: 10.1186/S12888-018-1682-2  0.01
2018 Weinberger AH, Platt J, Copeland J, Goodwin RD. Is Cannabis Use Associated With Increased Risk of Cigarette Smoking Initiation, Persistence, and Relapse? Longitudinal Data From a Representative Sample of US Adults. The Journal of Clinical Psychiatry. 79. PMID 29570966 DOI: 10.4088/Jcp.17M11522  0.01
2018 Mücke M, Weier M, Carter C, Copeland J, Degenhardt L, Cuhls H, Radbruch L, Häuser W, Conrad R. Systematic review and meta-analysis of cannabinoids in palliative medicine. Journal of Cachexia, Sarcopenia and Muscle. PMID 29400010 DOI: 10.1002/Jcsm.12273  0.01
2017 Goodwin RD, Pacek LR, Copeland J, Moeller SJ, Dierker L, Weinberger A, Gbedemah M, Zvolensky MJ, Wall MM, Hasin DS. Trends in Daily Cannabis Use Among Cigarette Smokers: United States, 2002-2014. American Journal of Public Health. e1-e6. PMID 29161058 DOI: 10.2105/Ajph.2017.304050  0.01
2017 Albertella L, Le Pelley ME, Copeland J. Cannabis use in early adolescence is associated with higher negative schizotypy in females. European Psychiatry : the Journal of the Association of European Psychiatrists. 45: 235-241. PMID 28957793 DOI: 10.1016/J.Eurpsy.2017.07.009  0.01
2017 Albertella L, Copeland J, Pearson D, Watson P, Wiers RW, Le Pelley ME. Selective attention moderates the relationship between attentional capture by signals of nondrug reward and illicit drug use. Drug and Alcohol Dependence. 175: 99-105. PMID 28411561 DOI: 10.1016/J.Drugalcdep.2017.01.041  1
2017 Rowe R, Berger I, Yaseen B, Copeland J. Risk and blood-borne virus testing among men who inject image and performance enhancing drugs, Sydney, Australia. Drug and Alcohol Review. PMID 28244160 DOI: 10.1111/Dar.12467  0.01
2017 Copeland J, Rooke S, Rodriquez D, Norberg MM, Gibson L. Comparison of brief versus extended personalised feedback in an online intervention for cannabis users: Short-term findings of a randomised trial. Journal of Substance Abuse Treatment. PMID 28162849 DOI: 10.1016/J.Jsat.2017.01.009  0.36
2017 Pokorski I, Clement N, Phung N, Weltman M, Fu S, Copeland J. Cannabidiol in the management of in-patient cannabis withdrawal: clinical case series Future Neurology. 12: 133-140. DOI: 10.2217/Fnl-2016-0035  0.01
2017 Copeland J. Feasibility Trial of a Brief Cannabis Use Intervention Delivered by Telephone Global Journal of Addiction & Rehabilitation Medicine. 1. DOI: 10.19080/GJARM.2017.01.555570  0.01
2017 Copeland J, Rooke S, Gibson L. Comparison of brief versus extended feedback in an online intervention for cannabis users: A randomised controlled trial Drug and Alcohol Dependence. 171. DOI: 10.1016/J.Drugalcdep.2016.08.137  0.36
2017 Copeland J, Pokorski I, Gibson L. Overview of Current State-of-the-Art Treatments for Cannabis Use Disorders, and Future Directions Current Addiction Reports. 4: 82-89. DOI: 10.1007/S40429-017-0151-1  0.36
2016 Copeland J, Gates P, Pokorski I. A Narrative Review of Psychological Cannabis Use Treatments With And Without Pharmaceutical Adjunct. Current Pharmaceutical Design. PMID 27587205 DOI: 10.2174/1381612822666160831094811  0.01
2016 Albertella L, Le Pelley ME, Copeland J. Frequent Cannabis Use Is Associated With Reduced Negative Priming Among Females. Experimental and Clinical Psychopharmacology. PMID 27337025 DOI: 10.1037/Pha0000085  1
2016 Copeland J, Pokorski I. Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review. Substance Abuse and Rehabilitation. 7: 41-53. PMID 27217809 DOI: 10.2147/Sar.S89857  0.01
2016 Gates PJ, Sabioni P, Copeland J, Le Foll B, Gowing L. Psychosocial interventions for cannabis use disorder. The Cochrane Database of Systematic Reviews. 5: CD005336. PMID 27149547 DOI: 10.1002/14651858.Cd005336.Pub4  1
2016 Rowe R, Berger I, Copeland J. “No pain, no gainz”? Performance and image-enhancing drugs, health effects and information seeking Drugs: Education, Prevention and Policy. 1-9. DOI: 10.1080/09687637.2016.1207752  1
2015 Lewis J, Molnar A, Allsop D, Copeland J, Fu S. Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users. International Journal of Legal Medicine. PMID 26233612 DOI: 10.1007/S00414-015-1241-Z  1
2015 Albertella L, Le Pelley ME, Copeland J. Cannabis use, schizotypy, and negative priming. Psychiatry Research. 228: 404-10. PMID 26154815 DOI: 10.1016/J.Psychres.2015.05.074  1
2015 Gates P, Albertella L, Copeland J. Cannabis withdrawal and sleep: A systematic review of human studies. Substance Abuse. 0. PMID 25893849 DOI: 10.1080/08897077.2015.1023484  1
2015 Allsop DJ, Lintzeris N, Copeland J, Dunlop A, McGregor IS. Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal. Clinical Pharmacology and Therapeutics. 97: 571-4. PMID 25777582 DOI: 10.1002/Cpt.109  1
2015 Allsop DJ, Copeland J. Age at first cannabis use moderates EEG markers of recovery from cannabis Journal of Substance Use. 1-7. DOI: 10.3109/14659891.2015.1040090  1
2015 Albertella L, Le Pelley M, Copeland J. Cannabis use, schizotypy, and attentional inhibition Drug and Alcohol Dependence. 156: e5. DOI: 10.1016/J.Drugalcdep.2015.07.931  0.01
2015 Webb L, Clement N, Matalon E, Joel T, Copeland J. A very brief intervention for cannabis users in an emergency department setting Drug and Alcohol Dependence. 156. DOI: 10.1016/J.Drugalcdep.2015.07.633  0.01
2015 Rooke S, Webb L, Albertella L, Copeland J. A smartphone application for managing cannabis use Drug and Alcohol Dependence. 156: e192. DOI: 10.1016/J.Drugalcdep.2015.07.516  0.01
2015 Khan SR, Striley CW, Copeland J, Kurtz SP, Cottler L. Risk of Sexual Abuse among Ecstasy Users Differs by Gender and Other Drug Use Drug and Alcohol Dependence. 156. DOI: 10.1016/J.Drugalcdep.2015.07.304  0.01
2015 Copeland J, Acharaya S, Howard J. Cannabis, Lord Shiva and holy men: Cannabis use among Sadhus in Nepal Drug and Alcohol Dependence. 156. DOI: 10.1016/J.Drugalcdep.2015.07.1048  0.01
2015 Copeland J, Allsop DJ. Specialist ‘cannabis only’ clinics in NSW, Australia: Client and treatment characteristics and associations with treatment-seeking behavior Drug and Alcohol Dependence. 146. DOI: 10.1016/J.Drugalcdep.2014.09.148  0.01
2014 Silins E, Horwood LJ, Patton GC, Fergusson DM, Olsson CA, Hutchinson DM, Spry E, Toumbourou JW, Degenhardt L, Swift W, Coffey C, Tait RJ, Letcher P, Copeland J, Mattick RP, et al. Young adult sequelae of adolescent cannabis use: an integrative analysis. The Lancet. Psychiatry. 1: 286-93. PMID 26360862 DOI: 10.1016/S2215-0366(14)70307-4  0.01
2014 Kelly E, Newton N, Stapinski L, Slade T, Barrett EL, Conrod PJ, Teesson M. Substance use and related harms among adolescent bullies, victims and bully-victims Drug and Alcohol Review. 33. PMID 25381832 DOI: 10.1111/Dar.12222  0.01
2014 Norberg MM, Hides L, Olivier J, Khawar L, McKetin R, Copeland J. Brief interventions to reduce Ecstasy use: a multi-site randomized controlled trial. Behavior Therapy. 45: 745-59. PMID 25311285 DOI: 10.1016/J.Beth.2014.05.006  1
2014 Bohanna I, Bird K, Copeland J, Roberts N, Clough A. A service-level action research intervention to improve identification and treatment of cannabis and related mental health issues in young Indigenous Australians: a study protocol. Bmj Open. 4: e005689. PMID 25082422 DOI: 10.1136/Bmjopen-2014-005689  1
2014 Copeland J, Allsop D. Dedicated 'cannabis only' treatment clinics in New South Wales, Australia: client and treatment characteristics and associations with first-time treatment seeking. Drug and Alcohol Review. 33: 565-71. PMID 24902861 DOI: 10.1111/Dar.12166  1
2014 Gates P, Jaffe A, Copeland J. Cannabis smoking and respiratory health: consideration of the literature. Respirology (Carlton, Vic.). 19: 655-62. PMID 24831571 DOI: 10.1111/Resp.12298  1
2014 Malouff JM, Rooke SE, Copeland J. Experiences of marijuana-vaporizer users. Substance Abuse. 35: 127-8. PMID 24821347 DOI: 10.1080/08897077.2013.823902  1
2014 Gates PJ, Albertella L, Copeland J. The effects of cannabinoid administration on sleep: a systematic review of human studies. Sleep Medicine Reviews. 18: 477-87. PMID 24726015 DOI: 10.1016/J.Smrv.2014.02.005  1
2014 McKetin R, Copeland J, Norberg MM, Bruno R, Hides L, Khawar L. The effect of the ecstasy 'come-down' on the diagnosis of ecstasy dependence. Drug and Alcohol Dependence. 139: 26-32. PMID 24703083 DOI: 10.1016/J.Drugalcdep.2014.02.697  1
2014 Molnar A, Fu S, Lewis J, Allsop DJ, Copeland J. The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS. Forensic Science International. 238: 113-9. PMID 24699310 DOI: 10.1016/J.Forsciint.2014.03.004  1
2014 Allsop DJ, Dunlop AJ, Saddler C, Rivas GR, McGregor IS, Copeland J. Changes in cigarette and alcohol use during cannabis abstinence. Drug and Alcohol Dependence. 138: 54-60. PMID 24613633 DOI: 10.1016/J.Drugalcdep.2014.01.022  1
2014 Allsop DJ, Copeland J, Lintzeris N, Dunlop AJ, Montebello M, Sadler C, Rivas GR, Holland RM, Muhleisen P, Norberg MM, Booth J, McGregor IS. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial. Jama Psychiatry. 71: 281-91. PMID 24430917 DOI: 10.1001/Jamapsychiatry.2013.3947  1
2014 Rooke SE, Gates PJ, Norberg MM, Copeland J. Applying technology to the treatment of cannabis use disorder: comparing telephone versus Internet delivery using data from two completed trials. Journal of Substance Abuse Treatment. 46: 78-84. PMID 24051076 DOI: 10.1016/J.Jsat.2013.08.007  1
2014 Silins E, Horwood LJ, Patton GC, Fergusson DM, Olsson CA, Hutchinson DM, Spry E, Toumbourou JW, Degenhardt L, Swift W, Coffey C, Tait RJ, Letcher P, Copeland J, Mattick RP, et al. Young adult sequelae of adolescent cannabis use: An integrative analysis The Lancet Psychiatry. 1: 286-293. DOI: 10.1016/S2215-0366(14)70307-4  1
2014 Albertella L, Le Pelley ME, Copeland J. Cannabis use, schizotypy, and negative priming Psychiatry Research. DOI: 10.1016/j.psychres.2015.05.074  1
2014 Norberg M, Khawar L, Copeland J, Olivier J. Efficacy of brief treatment for ecstasy use Drug and Alcohol Dependence. 140: e162-e163. DOI: 10.1016/J.Drugalcdep.2014.02.458  0.01
2014 Copeland J, Albertella L, Norberg M, Rooke S. A smart phone application for cannabis-related problems Drug and Alcohol Dependence. 140: e38. DOI: 10.1016/J.Drugalcdep.2014.02.124  0.01
2014 Bruno R, Allsop DJ, Copeland J, Lintzeris N, McGregor I, Norberg M, Dunlop A, Montebello M, Sadler C, Holland R, Rivas G. The impact of Sativex® on cognitive function during treatment for cannabis withdrawal Drug and Alcohol Dependence. 140: e22. DOI: 10.1016/J.Drugalcdep.2014.02.082  0.01
2014 Allsop DJ, Alperstein D, Copeland J. Neural markers for recovery in cannabis withdrawal Drug and Alcohol Dependence. 140. DOI: 10.1016/J.Drugalcdep.2014.02.033  0.01
2014 Norberg MM, Perry U, Mackenzie J, Copeland J. MET Plus CBT for Ecstasy Use When Clients Are Depressed: A Case Series Cognitive and Behavioral Practice. 21: 55-63. DOI: 10.1016/J.Cbpra.2013.06.002  1
2013 Klenowski P, Holgate J, Bellingham M, Molenaar P, Bartlett SE. Investigating the Contribution of Beta1 Adrenoceptors in the Development of Alcohol Dependence Drug and Alcohol Review. 32: 45-46. PMID 24304294 DOI: 10.1111/Dar.12077  0.01
2013 Banbury A, Zask A, Carter SM, van Beurden E, Tokley R, Passey M, Copeland J. Smoking mull: a grounded theory model on the dynamics of combined tobacco and cannabis use among adult men. Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals. 24: 143-50. PMID 24168742 DOI: 10.1071/He13037  1
2013 Rogerson B, Copeland J, Buttner P, Bohanna I, Cadet-James Y, Sarnyai Z, Clough AR. An exploratory study of cannabis withdrawal among Indigenous Australian prison inmates: study protocol. Bmj Open. 3. PMID 23793690 DOI: 10.1136/Bmjopen-2013-002951  1
2013 Copeland J, Rooke S, Swift W. Changes in cannabis use among young people: impact on mental health. Current Opinion in Psychiatry. 26: 325-9. PMID 23689549 DOI: 10.1097/Yco.0B013E328361Eae5  1
2013 Rooke SE, Norberg MM, Copeland J, Swift W. Health outcomes associated with long-term regular cannabis and tobacco smoking. Addictive Behaviors. 38: 2207-13. PMID 23501136 DOI: 10.1016/J.Addbeh.2013.01.013  1
2013 Rooke S, Copeland J, Norberg M, Hine D, McCambridge J. Effectiveness of a self-guided web-based cannabis treatment program: randomized controlled trial. Journal of Medical Internet Research. 15: e26. PMID 23470329 DOI: 10.2196/Jmir.2256  1
2013 Gates PJ, Copeland J, Norberg MM, Digiusto E. A response to Tucker (2012). Addiction (Abingdon, England). 108: 826-7. PMID 23297681 DOI: 10.1111/Add.12102  1
2013 Bashford J, Copeland J, Flett R. Cannabis use and disorder transitions among a mixed community sample of at-risk adolescents and adults: A prospective New Zealand study The Open Addiction Journal. 6: 6-15. DOI: 10.2174/1874941001306010006  0.01
2013 Copeland J, Dillon P. Ketamine Principles of Addiction. 733-741. DOI: 10.1016/B978-0-12-398336-7.00074-7  1
2012 Norberg MM, Battisti RA, Copeland J, Hermens DF, Hickie IB. Two Sides of the Same Coin: Cannabis Dependence and Mental Health Problems in Help-Seeking Adolescent and Young Adult Outpatients. International Journal of Mental Health and Addiction. 10: 818-828. PMID 23243411 DOI: 10.1007/S11469-012-9378-1  1
2012 Allsop DJ, Copeland J, Norberg MM, Fu S, Molnar A, Lewis J, Budney AJ. Quantifying the clinical significance of cannabis withdrawal. Plos One. 7: e44864. PMID 23049760 DOI: 10.1371/Journal.Pone.0044864  1
2012 Norberg MM, Gates P, Dillon P, Kavanagh DJ, Manocha R, Copeland J. Screening and managing cannabis use: comparing GP's and nurses' knowledge, beliefs, and behavior. Substance Abuse Treatment, Prevention, and Policy. 7: 31. PMID 22827931 DOI: 10.1186/1747-597X-7-31  1
2012 Bujarski SJ, Norberg MM, Copeland J. The association between distress tolerance and cannabis use-related problems: the mediating and moderating roles of coping motives and gender. Addictive Behaviors. 37: 1181-4. PMID 22698896 DOI: 10.1016/J.Addbeh.2012.05.014  1
2012 Gates PJ, Norberg MM, Copeland J, Digiusto E. Randomized controlled trial of a novel cannabis use intervention delivered by telephone. Addiction (Abingdon, England). 107: 2149-58. PMID 22632139 DOI: 10.1111/J.1360-0443.2012.03953.X  1
2012 Donato-Hunt C, Munot S, Copeland J. Alcohol, tobacco and illicit drug use among six culturally diverse communities in Sydney. Drug and Alcohol Review. 31: 881-9. PMID 22404499 DOI: 10.1111/J.1465-3362.2012.00417.X  0.01
2012 Calabria B, Swift W, Slade T, Hall W, Copeland J. The perceived health risks of cannabis use in an Australian household survey. Drug and Alcohol Review. 31: 809-12. PMID 22385157 DOI: 10.1111/J.1465-3362.2012.00421.X  0.01
2012 Norberg MM, Mackenzie J, Copeland J. Quantifying cannabis use with the timeline followback approach: a psychometric evaluation. Drug and Alcohol Dependence. 121: 247-52. PMID 21955364 DOI: 10.1016/J.Drugalcdep.2011.09.007  1
2012 Norberg MM, Wright T, Hickey K, Copeland J. A postal intervention for dependent cannabis users. Drug and Alcohol Review. 31: 320-6. PMID 21605203 DOI: 10.1111/J.1465-3362.2011.00317.X  1
2012 Gates P, Copeland J, Swift W, Martin G. Barriers and facilitators to cannabis treatment. Drug and Alcohol Review. 31: 311-9. PMID 21521384 DOI: 10.1111/J.1465-3362.2011.00313.X  0.01
2012 Alperstein D, Copeland J. Evaluating the Impact of Training Health Professionals to Deliver Brief Motivational and Skills-Based Interventions for Cannabis Use Disorder Journal of Tropical Psychology. 2. DOI: 10.1017/JTP.2012.1  0.01
2012 Rooke S, Malouff J, Copeland J. Effects of Repeated Exposure to a Graphic Smoking Warning Image Current Psychology. 31: 282-290. DOI: 10.1007/S12144-012-9147-0  0.36
2012 Copeland J, Howard J. Cannabis Use Disorders Clinical Handbook of Adolescent Addiction. 202-212. DOI: 10.1002/9781118340851.ch20  1
2011 Rooke SE, Norberg MM, Copeland J. Successful and unsuccessful cannabis quitters: comparing group characteristics and quitting strategies. Substance Abuse Treatment, Prevention, and Policy. 6: 30. PMID 22074446 DOI: 10.1186/1747-597X-6-30  1
2011 Allsop DJ, Norberg MM, Copeland J, Fu S, Budney AJ. The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. Drug and Alcohol Dependence. 119: 123-9. PMID 21724338 DOI: 10.1016/J.Drugalcdep.2011.06.003  1
2011 Arcuri AJ, Howard J, Norberg M, Copeland J, Toson B. Young cannabis users in residential treatment: as distressed as other clients. Substance Use & Misuse. 46: 1335-45. PMID 21615223 DOI: 10.3109/10826084.2011.580034  1
2011 Copeland J. The glass ceiling on evidence of cannabis related harms - flawed or just false? Addiction (Abingdon, England). 106: 249-51; discussion 2. PMID 21208316 DOI: 10.1111/J.1360-0443.2010.03273.X  0.01
2011 Copeland J. Application of technology in the prevention and treatment of substance use disorders and related problems: opportunities and challenges. Substance Use & Misuse. 46: 112-3. PMID 21190411 DOI: 10.3109/10826084.2011.521423  0.01
2011 Gates P, Copeland J, Norberg M, Digiusto E. Caller satisfaction with the Cannabis Information and Helpline. Journal of Telemedicine and Telecare. 17: 93-8. PMID 21163813 DOI: 10.1258/Jtt.2010.100509  1
2011 Frewen AR, Copeland J. Are Australian Treatment Agencies Equipped to Deal With Rising Numbers of Presentations for Cannabis Issues? Journal of Tropical Psychology. 1: 27-30. DOI: 10.1375/JTP.1.1.27  0.01
2011 Lemon J, Stevenson R, Gates P, Copeland J. Palatability, Familiarity, and Underage, Immoderate Drinking Journal of Child and Adolescent Substance Abuse. 20: 437-449. DOI: 10.1080/1067828X.2011.614896  1
2010 Rooke S, Thorsteinsson E, Karpin A, Copeland J, Allsop D. Computer-delivered interventions for alcohol and tobacco use: a meta-analysis. Addiction (Abingdon, England). 105: 1381-90. PMID 20528806 DOI: 10.1111/J.1360-0443.2010.02975.X  0.36
2010 Bashford J, Flett R, Copeland J. The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults. Addiction (Abingdon, England). 105: 615-25. PMID 20403014 DOI: 10.1111/J.1360-0443.2009.02859.X  1
2010 Proudfoot H, Vogl L, Swift W, Martin G, Copeland J. Development of a short cannabis problems questionnaire for adolescents in the community. Addictive Behaviors. 35: 734-7. PMID 20356683 DOI: 10.1016/J.Addbeh.2010.03.012  0.01
2010 Roxburgh A, Hall WD, Degenhardt L, McLaren J, Black E, Copeland J, Mattick RP. The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007. Addiction (Abingdon, England). 105: 1071-9. PMID 20331568 DOI: 10.1111/J.1360-0443.2010.02903.X  0.01
2010 Indig D, Copeland J, Conigrave KM, Arcuri A. Characteristics and comorbidity of drug and alcohol-related emergency department presentations detected by nursing triage text. Addiction (Abingdon, England). 105: 897-906. PMID 20148784 DOI: 10.1111/J.1360-0443.2009.02857.X  1
2010 Leung KS, Ben Abdallah A, Copeland J, Cottler LB. Modifiable risk factors of ecstasy use: risk perception, current dependence, perceived control, and depression. Addictive Behaviors. 35: 201-8. PMID 19880258 DOI: 10.1016/J.Addbeh.2009.10.003  0.01
2010 Martin G, Copeland J. Brief intervention for regular ecstasy (MDMA) users: Pilot randomized trial of a Check-up model Journal of Substance Use. 15: 131-142. DOI: 10.3109/14659890903075074  0.01
2009 Silins E, Copeland J, Dillon P. Patterns and harms of pharmaceutical drug use among ecstasy users in Australia. Adicciones. 21: 347-62. PMID 20011991  0.01
2009 Hughes K, Downing J, Bellis MA, Dillon P, Copeland J. The sexual behaviour of British backpackers in Australia. Sexually Transmitted Infections. 85: 477-82. PMID 19826066 DOI: 10.1136/Sti.2009.036921  0.01
2009 Indig D, Copeland J, Conigrave KM. Comparing methods of detecting alcohol-related emergency department presentations. Emergency Medicine Journal : Emj. 26: 596-600. PMID 19625559 DOI: 10.1136/Emj.2008.067348  0.01
2009 Copeland J, Swift W. Cannabis use disorder: epidemiology and management. International Review of Psychiatry (Abingdon, England). 21: 96-103. PMID 19367503 DOI: 10.1080/09540260902782745  0.01
2009 Indig D, Copeland J, Conigrave KM, Rotenko I. Attitudes and beliefs of emergency department staff regarding alcohol-related presentations. International Emergency Nursing. 17: 23-30. PMID 19135012 DOI: 10.1016/J.Ienj.2008.08.002  0.01
2009 Simpson M, Lawrinson P, Copeland J, Gates P. The Alcohol Treatment Outcome Measure (ATOM): a new clinical tool for standardising outcome measurement for alcohol treatment. Addictive Behaviors. 34: 121-4. PMID 18945550 DOI: 10.1016/J.Addbeh.2008.09.007  0.01
2009 Winstock AR, Lea T, Copeland J. Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study. Journal of Psychopharmacology (Oxford, England). 23: 84-93. PMID 18515451 DOI: 10.1177/0269881108089584  0.01
2009 Silins E, Copeland J, Dillon P. Perceptions of methamphetamine- and GHB-related presentations among emergency medicine healthcare professionals: An exploratory study Drugs-Education Prevention and Policy. 17: 181-187. DOI: 10.3109/09687630902729610  0.01
2009 Copeland J, Peters R, Dillon P. Correspondence: Anabolic-androgenic steroid dependence in a woman Australian and New Zealand Journal of Psychiatry. 32: 589-592. DOI: 10.3109/00048679809068337  0.01
2009 Silins E, Copeland J, Dillon P. Pautas y problemas derivados del consumo de fármacos entre los consumidores de éxtasis en Australia Adicciones. 21: 347-362. DOI: 10.20882/Adicciones.224  0.01
2009 Lawrinson P, Roche A, Copeland J. Optimizing clinical care through implementation of outcome monitoring systems Drugs-Education Prevention and Policy. 16: 250-259. DOI: 10.1080/09687630902876015  0.01
2008 Indig D, Copeland J, Conigrave KM, Rotenko I. Why are alcohol-related emergency department presentations under-detected? An exploratory study using nursing triage text. Drug and Alcohol Review. 27: 584-90. PMID 19378442 DOI: 10.1080/09595230801935680  0.01
2008 Larance B, Degenhardt L, Copeland J, Dillon P. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Drug and Alcohol Review. 27: 679-86. PMID 18825549 DOI: 10.1080/09595230802392568  0.01
2008 Indig D, Copeland J, Conigrave KM. Young people who attend specialist alcohol treatment: who are they and do they need special treatment? Australian and New Zealand Journal of Public Health. 32: 336-40. PMID 18782396 DOI: 10.1111/J.1753-6405.2008.00251.X  0.01
2008 Scheier LM, Ben Abdallah A, Inciardi JA, Copeland J, Cottler LB. Tri-city study of Ecstasy use problems: a latent class analysis. Drug and Alcohol Dependence. 98: 249-63. PMID 18674872 DOI: 10.1016/J.Drugalcdep.2008.06.008  0.01
2008 Roxburgh A, Degenhardt L, Copeland J, Larance B. Drug dependence and associated risks among female street-based sex workers in the greater Sydney area, Australia. Substance Use & Misuse. 43: 1202-17. PMID 18649239 DOI: 10.1080/10826080801914410  0.01
2008 Finney Lamb CE, Boers M, Owens A, Copeland J, Sultana T. Exploring experiences and attitudes about health care complaints among pregnant women, mothers and staff at an Opioid Treatment Service. Australian Health Review : a Publication of the Australian Hospital Association. 32: 66-75. PMID 18241150 DOI: 10.1071/Ah080066  0.01
2008 Copeland J. Brief personalised motivational interviewing reduces frequency of marijuana use in regular users ambivalent to change. Evidence-Based Mental Health. 11: 22. PMID 18223057 DOI: 10.1136/Ebmh.11.1.22  0.01
2008 Martin G, Copeland J. The adolescent cannabis check-up: randomized trial of a brief intervention for young cannabis users. Journal of Substance Abuse Treatment. 34: 407-14. PMID 17869051 DOI: 10.1016/J.Jsat.2007.07.004  0.01
2008 Frewen A, Arcuri A, Harrison C, Copeland J, Britt H. Management of Cannabis and Psychostimulant Use among General Practice Patients Australian Journal of Primary Health. 14: 132-140. DOI: 10.1071/Py08045  0.01
2007 Stevenson RJ, Copeland J, Gates P. The role of experience in liking "read-to-drink" alcoholic beverages. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 21: 564-9. PMID 18072839 DOI: 10.1037/0893-164X.21.4.564  1
2007 Abdallah AB, Scheier LM, Inciardi JA, Copeland J, Cottler LB. A psycho-economic model of ecstasy consumption and related consequences: a multi-site study with community samples. Substance Use & Misuse. 42: 1651-84. PMID 17934989 DOI: 10.1080/10826080701208905  0.01
2007 Copeland J, Stevenson RJ, Gates P, Dillon P. Young Australians and alcohol: the acceptabllity of ready-to-drink (RTD) alcoholic beverages among 12-30-year-olds. Addiction (Abingdon, England). 102: 1740-6. PMID 17784899 DOI: 10.1111/J.1360-0443.2007.01970.X  1
2007 Silins E, Copeland J, Dillon P. Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk. The Australian and New Zealand Journal of Psychiatry. 41: 649-55. PMID 17620161 DOI: 10.1080/00048670701449237  0.01
2007 Copeland J, Maxwell JC. Cannabis treatment outcomes among legally coerced and non-coerced adults. Bmc Public Health. 7: 111. PMID 17567917 DOI: 10.1186/1471-2458-7-111  1
2007 Indig D, Eyeson-Annan M, Copeland J, Conigrave KM. The effects of alcohol consumption, psychological distress and smoking status on emergency department presentations in New South Wales, Australia. Bmc Public Health. 7: 46. PMID 17407557 DOI: 10.1186/1471-2458-7-46  0.01
2007 Gates P, Copeland J, Stevenson RJ, Dillon P. The influence of product packaging on young people's palatability rating for RTDS and other alcoholic beverages. Alcohol and Alcoholism (Oxford, Oxfordshire). 42: 138-42. PMID 17267439 DOI: 10.1093/Alcalc/Agl113  1
2007 Bellis MA, Hughes KE, Dillon P, Copeland J, Gates P. Effects of backpacking holidays in Australia on alcohol, tobacco and drug use of UK residents. Bmc Public Health. 7: 1. PMID 17199891 DOI: 10.1186/1471-2458-7-1  1
2007 Lawrinson P, Copeland J, Gerber S, Gilmour S. Determining a cut-off on the Severity of Dependence Scale (SDS) for alcohol dependence. Addictive Behaviors. 32: 1474-9. PMID 17081703 DOI: 10.1016/J.Addbeh.2006.09.005  0.01
2006 Copeland J. Cannabis use, depression and public health. Addiction (Abingdon, England). 101: 1380. PMID 16968334 DOI: 10.1111/J.1360-0443.2006.01640.X  0.01
2006 Lawrinson P, Copeland J, Indig D. Regional differences in injecting practices and other substance use-related behaviour among entrants into opioid maintenance pharmacotherapy treatment in New South Wales, Australia. Drug and Alcohol Dependence. 82: S95-102. PMID 16769453 DOI: 10.1016/S0376-8716(06)80015-3  0.01
2006 Roxburgh A, Degenhardt L, Copeland J. Posttraumatic stress disorder among female street-based sex workers in the greater Sydney area, Australia. Bmc Psychiatry. 6: 24. PMID 16719928 DOI: 10.1186/1471-244X-6-24  0.01
2006 Martin G, Copeland J, Gilmour S, Gates P, Swift W. The Adolescent Cannabis Problems Questionnaire (CPQ-A): psychometric properties. Addictive Behaviors. 31: 2238-48. PMID 16626880 DOI: 10.1016/J.Addbeh.2006.03.001  0.01
2006 Martin G, Copeland J, Gates P, Gilmour S. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off. Drug and Alcohol Dependence. 83: 90-3. PMID 16310973 DOI: 10.1016/J.Drugalcdep.2005.10.014  0.01
2006 Copeland J, Dillon P, Gascoigne M. Ecstasy and the concomitant use of pharmaceuticals. Addictive Behaviors. 31: 367-70. PMID 15961251 DOI: 10.1016/J.Addbeh.2005.05.025  0.01
2006 O'Callaghan FV, Reid A, Copeland J. Risk Perception and Cannabis Use in a Sample of Young Adults Journal of Substance Use. 11: 129-136. DOI: 10.1080/14659890500237366  0.01
2005 Martin G, Copeland J, Swift W. The Adolescent Cannabis Check-Up: feasibility of a brief intervention for young cannabis users. Journal of Substance Abuse Treatment. 29: 207-13. PMID 16183469 DOI: 10.1016/J.Jsat.2005.06.005  0.01
2005 Degenhardt L, Copeland J, Dillon P. Recent trends in the use of "club drugs": an Australian review. Substance Use & Misuse. 40: 1241-56. PMID 16048815 DOI: 10.1081/Ja-200066777  0.01
2005 Copeland J, Gilmour S, Gates P, Swift W. The Cannabis Problems Questionnaire: factor structure, reliability, and validity. Drug and Alcohol Dependence. 80: 313-9. PMID 15916867 DOI: 10.1016/J.Drugalcdep.2005.04.009  0.01
2005 Lawrinson P, Copeland J, Indig D. Development and validation of a brief instrument for routine outcome monitoring in opioid maintenance pharmacotherapy services: the brief treatment outcome measure (BTOM). Drug and Alcohol Dependence. 80: 125-33. PMID 15869845 DOI: 10.1016/J.Drugalcdep.2005.04.001  0.01
2005 Copeland J. Addiction and Life Course Addiction. 100: 1032-1033. DOI: 10.1111/J.1360-0443.2005.01190.X  0.01
2005 Copeland J. Cannabis‐related problems and their management Drugs and Alcohol Today. 5: 20-25. DOI: 10.1108/17459265200500024  0.01
2005 Copeland J, Dillon P. The health and psycho-social consequences of ketamine use International Journal of Drug Policy. 16: 122-131. DOI: 10.1016/J.Drugpo.2004.12.003  0.01
2004 Copeland J, Indig D. Patterns and correlates of treatment: findings of the 2000-2001 NSW minimum dataset of clients of alcohol and other drug treatment services. Drug and Alcohol Review. 23: 185-94. PMID 15370025 DOI: 10.1080/09595230410001704172  0.01
2004 Copeland J, Martin G. Web-based interventions for substance use disorders: a qualitative review. Journal of Substance Abuse Treatment. 26: 109-16. PMID 15050088 DOI: 10.1016/S0740-5472(03)00165-X  0.01
2004 Copeland J. Developments in the treatment of cannabis use disorder Current Opinion in Psychiatry. 17: 161-167. DOI: 10.1097/00001504-200405000-00003  0.01
2003 Howard J, Lennings CJ, Copeland J. Suicidal behavior in a young offender population. Crisis-the Journal of Crisis Intervention and Suicide Prevention. 24: 98-104. PMID 14518642 DOI: 10.1027//0227-5910.24.3.98  0.01
2003 Copeland J, Howard J, Keogh T, Seidler K. Patterns and correlates of substance use amongst juvenile detainees in New South Wales 1989-99. Drug and Alcohol Review. 22: 15-20. PMID 12745354 DOI: 10.1080/0959523021000059785  0.01
2003 Dillon P, Copeland J, Jansen K. Patterns of use and harms associated with non-medical ketamine use. Drug and Alcohol Dependence. 69: 23-8. PMID 12536063 DOI: 10.1016/S0376-8716(02)00243-0  0.01
2003 Lennings CJ, Copeland J, Howard J. Substance use patterns of young offenders and violent crime Aggressive Behavior. 29: 414-422. DOI: 10.1002/Ab.10048  0.01
2002 Copeland J. Drug Misuse and Motherhood Addiction. 97: 1228-1228. DOI: 10.1046/J.1360-0443.2002.T01-1-00247.X  0.01
2001 Copeland J, Swift W, Roffman R, Stephens R. A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. Journal of Substance Abuse Treatment. 21: 55-64. PMID 11551733 DOI: 10.1016/S0740-5472(01)00179-9  0.01
2001 Copeland J, Swift W, Rees V. Clinical profile of participants in a brief intervention program for cannabis use disorder Journal of Substance Abuse Treatment. 20: 45-52. PMID 11239727 DOI: 10.1016/S0740-5472(00)00148-3  0.01
2001 Copeland J, Conroy A. Australian National Minimum Data Set for Clients of Alcohol and Other Drug Treatment Services: Findings of the national pilot and developments in implementation Drug and Alcohol Review. 20: 295-298. DOI: 10.1080/09595230126338  1
2000 Reid A, Lynskey M, Copeland J. Cannabis use among Australian adolescents: findings of the 1998 National Drug Strategy Household Survey. Australian and New Zealand Journal of Public Health. 24: 596-602. PMID 11215007 DOI: 10.1111/J.1467-842X.2000.Tb00523.X  0.01
2000 Copeland J, Peters R, Dillon P. Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users Drug and Alcohol Dependence. 60: 91-96. PMID 10821993 DOI: 10.1016/S0376-8716(00)80011-3  1
2000 Swift W, Hall W, Copeland J. One year follow-up of cannabis dependence among long-term users in Sydney, Australia Drug and Alcohol Dependence. 59: 309-318. PMID 10812291 DOI: 10.1016/S0376-8716(99)00131-3  0.01
2000 Swift W, Copeland J, Lenton S. Cannabis and harm reduction Drug and Alcohol Review. 19: 101-112. DOI: 10.1080/09595230096200  0.01
1999 Dillon P, Copeland J, Peters R. Exploring the relationship between male homo/bi-sexuality, body image and steroid use Culture, Health and Sexuality. 1: 317-327. DOI: 10.1080/136910599300914  1
1999 Peters R, Copeland J, Dillon P. Anabolic-androgenic steroids: User characteristics, motivations, and deterrents Psychology of Addictive Behaviors. 13: 232-242. DOI: 10.1037/0893-164X.13.3.232  1
1998 Swift W, Copeland J. Treatment needs of women with alcohol and other drug problems: experiences and views of Australian treatment personnel. Drug and Alcohol Review. 17: 59-67. PMID 16203469 DOI: 10.1080/09595239800187601  0.01
1998 Swift W, Copeland J, Hall W. Choosing a diagnostic cut‐off for cannabis dependence Addiction. 93: 1681-1692. PMID 9926531 DOI: 10.1046/J.1360-0443.1998.931116816.X  0.01
1998 Swift W, Hall W, Copeland J. Characteristics of Long-Term Cannabis Users in Sydney, Australia European Addiction Research. 4: 190-197. PMID 9852371 DOI: 10.1159/000018952  0.01
1998 Jarvis TJ, Copeland J, Walton L. Exploring the nature of the relationship between child sexual abuse and substance use among women Addiction. 93: 865-875. PMID 9744122 DOI: 10.1046/J.1360-0443.1998.9368658.X  1
1998 Copeland J, Howard J, Fleischmann S. Gender, HIV knowledge and risk-taking behaviour among substance using adolescents in custody in New South Wales Journal of Substance Use. 3: 206-212. DOI: 10.3109/14659899809053503  0.01
1998 Copeland J. A qualitative study of self-managed change in substance dependence among women: Contemporary Drug Problems. 25: 321-345. DOI: 10.1177/009145099802500204  0.01
1998 Diamant K, Fischer G, Schneider C, Lenzinger E, Pezawas L, Schindler S, Eder H, Vrasti R, Grant BF, Chatterji S, Üstün BT, Mager D, Olteanu I, Badoi M, Källmén H, ... ... Copeland J, et al. Addiction Research in Switzerland and Elsewhere in Europe European Addiction Research. 4: 143-143. DOI: 10.1159/000018946  0.01
1997 Copeland J, Rankin J. Maximizing the opportunity for a national minimum data set. Drug and Alcohol Review. 16: 205-6. PMID 16203428 DOI: 10.1080/09595239800187371  0.01
1997 Jarvis TJ, Copeland J. Child sexual abuse as a predictor of psychiatric co-morbidity and its implications for drug and alcohol treatment Drug and Alcohol Dependence. 49: 61-69. PMID 9476701 DOI: 10.1016/S0376-8716(97)00139-7  1
1997 Copeland J. A qualitative study of barriers to formal treatment among women who self-managed change in addictive behaviours. Journal of Substance Abuse Treatment. 14: 183-190. PMID 9258863 DOI: 10.1016/S0740-5472(96)00108-0  0.01
1997 Fennerty A, Reid A, O'Donnell M, Copeland J, Monie R. 813 A named nurse programme for the care of patients with lung cancer Lung Cancer. 18: 210. DOI: 10.1016/s0169-5002(97)80195-x  0.01
1996 Swift W, Copeland J. Treatment needs and experiences of Australian women with alcohol and other drug problems Drug and Alcohol Dependence. 40: 211-219. PMID 8861399 DOI: 10.1016/0376-8716(95)01209-5  0.01
1996 Swift W, Copeland J, Hall W. Characteristics of women with alcohol and other drug problems: findings of an Australian national survey. Addiction. 91: 1141-1150. PMID 8828242 DOI: 10.1046/J.1360-0443.1996.91811416.X  0.01
1993 Copeland J, Hall W, Didcott P, Biggs V. A comparison of a specialist women's alcohol and other drug treatment service with two traditional mixed-sex services: client characteristics and treatment outcome Drug and Alcohol Dependence. 32: 81-92. PMID 8387422 DOI: 10.1016/0376-8716(93)90025-L  0.01
1992 Copeland J, Hall W. A comparison of women seeking drug and alcohol treatment in a specialist women's and two traditional mixed-sex treatment services Addiction. 87: 1293-1302. PMID 1327337 DOI: 10.1111/J.1360-0443.1992.Tb02738.X  0.01
1992 Copeland J, Hall W. A comparison of predictors of treatment drop‐out of women seeking drug and alcohol treatment in a specialist women's and two traditional mixed‐sex treatment services Addiction. 87: 883-890. PMID 1326359 DOI: 10.1111/J.1360-0443.1992.Tb01983.X  0.01
Show low-probability matches.